Akili Inc Stock Fundamentals
AKLIDelisted Stock | USD 0.43 0.00 0.00% |
Akili Inc fundamentals help investors to digest information that contributes to Akili's financial success or failures. It also enables traders to predict the movement of Akili Stock. The fundamental analysis module provides a way to measure Akili's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akili stock.
Akili |
Akili Inc Company Shares Outstanding Analysis
Akili's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Akili Shares Outstanding | 78.73 M |
Most of Akili's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akili Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Akili Inc has 78.73 M of shares currently outstending. This is 56.39% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 86.23% higher than that of the company.
Akili Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Akili's current stock value. Our valuation model uses many indicators to compare Akili value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akili competition to find correlations between indicators driving Akili's intrinsic value. More Info.Akili Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akili's earnings, one of the primary drivers of an investment's value.Akili Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akili's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akili could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics of similar companies.Akili is currently under evaluation in shares outstanding category among its peers.
Akili Fundamentals
Return On Equity | -0.68 | |||
Return On Asset | -0.37 | |||
Operating Margin | (28.37) % | |||
Current Valuation | (15.56 M) | |||
Shares Outstanding | 78.73 M | |||
Shares Owned By Insiders | 23.21 % | |||
Shares Owned By Institutions | 61.47 % | |||
Number Of Shares Shorted | 271.35 K | |||
Price To Book | 0.35 X | |||
Price To Sales | 12.31 X | |||
Revenue | 1.68 M | |||
Gross Profit | (118 K) | |||
EBITDA | (60.14 M) | |||
Net Income | (59.49 M) | |||
Cash And Equivalents | 45.62 M | |||
Cash Per Share | 0.53 X | |||
Total Debt | 15.48 M | |||
Debt To Equity | 0.79 % | |||
Current Ratio | 4.78 X | |||
Book Value Per Share | 0.64 X | |||
Cash Flow From Operations | (57.87 M) | |||
Short Ratio | 0.31 X | |||
Earnings Per Share | (0.61) X | |||
Target Price | 0.65 | |||
Number Of Employees | 68 | |||
Beta | 1.73 | |||
Market Capitalization | 34.1 M | |||
Total Asset | 80.38 M | |||
Retained Earnings | (299.78 M) | |||
Working Capital | 65.06 M | |||
Net Asset | 80.38 M |
About Akili Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akili Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akili using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akili Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. Akili operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 127 people.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |